| Fatty acid oxidation-driven Src links mitochondrial energy reprogramming and oncogenic properties in triple-negative breast cancer JH Park, S Vithayathil, S Kumar, PL Sung, LE Dobrolecki, V Putluri, ... Cell reports 14 (9), 2154-2165, 2016 | 294 | 2016 |
| Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and β-catenin signaling YY Liu, V Gupta, GA Patwardhan, K Bhinge, Y Zhao, J Bao, H Mehendale, ... Molecular cancer 9, 1-15, 2010 | 189 | 2010 |
| A role for ceramide in driving cancer cell resistance to doxorubicin YY Liu, JY Yu, D Yin, GA Patwardhan, V Gupta, Y Hirabayashi, ... The FASEB Journal 22 (7), 2541-2551, 2008 | 173 | 2008 |
| Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells YY Liu, GA Patwardhan, K Bhinge, V Gupta, X Gu, SM Jazwinski Cancer research 71 (6), 2276-2285, 2011 | 94 | 2011 |
| Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells V Gupta, KN Bhinge, SB Hosain, K Xiong, X Gu, R Shi, MY Ho, KH Khoo, ... Journal of Biological Chemistry 287 (44), 37195-37205, 2012 | 81 | 2012 |
| The effect of soluble E-selectin on tumor progression and metastasis SA Kang, CA Blache, S Bajana, N Hasan, M Kamal, Y Morita, V Gupta, ... BMC cancer 16, 1-13, 2016 | 61 | 2016 |
| A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis GA Patwardhan, QJ Zhang, D Yin, V Gupta, J Bao, CE Senkal, ... PloS one 4 (9), e6938, 2009 | 59 | 2009 |
| The opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthase KN Bhinge, V Gupta, SB Hosain, SD Satyanarayanajois, SA Meyer, ... The international journal of biochemistry & cell biology 44 (11), 1770-1778, 2012 | 55 | 2012 |
| Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES) A Siddiqui, V Gupta, YY Liu, S Nazzal International journal of pharmaceutics 431 (1-2), 222-229, 2012 | 39 | 2012 |
| Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase V Gupta, GA Patwardhan, QJ Zhang, MC Cabot, SM Jazwinski, YY Liu Journal of lipid research 51 (4), 866-874, 2010 | 38 | 2010 |
| Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy G Patwardhan, V Gupta, J Huang, X Gu, YY Liu Biochemical pharmacology 80 (1), 72-79, 2010 | 33 | 2010 |
| Evaluation of anticancer agents using flow cytometry analysis of cancer stem cells V Gupta, QJ Zhang, YY Liu Drug Design and Discovery: Methods and Protocols, 179-191, 2011 | 32 | 2011 |
| Safety evaluation of intravenously administered mono-thioated aptamer against E-selectin in mice SA Kang, B Tsolmon, AP Mann, W Zheng, L Zhao, YD Zhao, DE Volk, ... Toxicology and applied pharmacology 287 (1), 86-92, 2015 | 16 | 2015 |
| Detection and enumeration of circulating tumor cells based on their invasive property H Wang, Y Hara, X Liu, JM Reuben, Y Xie, H Xu, G Bu, Y Pei, V Gupta, ... Oncotarget 6 (29), 27304, 2015 | 10 | 2015 |
| New Insights on Glucosylceramide Synthase in Cancer drug resistance and myelosuppression V Gupta, YY Liu Biochemistry & pharmacology: open access 2, 2013 | 3 | 2013 |
| An Advanced Histologic Method for Evaluation of Intestinal Adenomas in Mice Using Digital Slides JS Davis, V Gupta, M Gagea, X Wu PloS one 11 (3), e0151463, 2016 | 2 | 2016 |
Yong-Yu LiuUniversity of Louisiana at Monroe在 ulm.edu 的电子邮件经过验证
